Minerva medicaPub Date : 2023-12-01Epub Date: 2023-06-16DOI: 10.23736/S0026-4806.23.08728-1
Ying Zhao, Li Ding, Junbi Xu, Bin Peng
{"title":"Ovarian torsion complicated with venous thromboembolism in pregnancy.","authors":"Ying Zhao, Li Ding, Junbi Xu, Bin Peng","doi":"10.23736/S0026-4806.23.08728-1","DOIUrl":"10.23736/S0026-4806.23.08728-1","url":null,"abstract":"","PeriodicalId":18671,"journal":{"name":"Minerva medica","volume":" ","pages":"893-895"},"PeriodicalIF":4.7,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9693526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Minerva medicaPub Date : 2023-12-01Epub Date: 2022-06-07DOI: 10.23736/S0026-4806.22.08186-1
Ling Li, Min Chen, Yaqin Zhou, Ruifang Gao, Yuanyuan Wang, Yonghua Zhang
{"title":"Effect of hierarchical nursing model on complications of hemodialysis patients in ICU and its effect evaluation.","authors":"Ling Li, Min Chen, Yaqin Zhou, Ruifang Gao, Yuanyuan Wang, Yonghua Zhang","doi":"10.23736/S0026-4806.22.08186-1","DOIUrl":"10.23736/S0026-4806.22.08186-1","url":null,"abstract":"","PeriodicalId":18671,"journal":{"name":"Minerva medica","volume":" ","pages":"902-904"},"PeriodicalIF":4.7,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45283172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Minerva medicaPub Date : 2023-12-01Epub Date: 2022-06-07DOI: 10.23736/S0026-4806.22.08018-1
Antonella Caminati, Maurizio Zompatori, Nicoletta Fuccillo, Andrea Sonaglioni, Davide Elia, Roberto Cassandro, Roberta Trevisan, Anna Rispoli, Giuseppe Pelosi, Sergio Harari
{"title":"Coronary artery calcium score is a prognostic factor for mortality in idiopathic pulmonary fibrosis.","authors":"Antonella Caminati, Maurizio Zompatori, Nicoletta Fuccillo, Andrea Sonaglioni, Davide Elia, Roberto Cassandro, Roberta Trevisan, Anna Rispoli, Giuseppe Pelosi, Sergio Harari","doi":"10.23736/S0026-4806.22.08018-1","DOIUrl":"10.23736/S0026-4806.22.08018-1","url":null,"abstract":"<p><strong>Background: </strong>Cardiovascular diseases are frequent in idiopathic pulmonary fibrosis (IPF) and impact on survival. We investigated the association of coronary artery calcium (CAC) score at IPF diagnosis and during mid-term follow-up, with adverse cardiovascular events and all-cause mortality.</p><p><strong>Methods: </strong>Consecutive patients with IPF were retrospectively analyzed. Demographic data, smoking history, comorbidities and pulmonary function tests (PFTs) were recorded. All patients had at least two chest high resolution computed tomography (HRCT) performed 2 years apart. The total CAC score and visual fibrotic score were calculated, and all clinically significant cardiovascular events and deaths were reported.</p><p><strong>Results: </strong>The population consisted of 79 patients (57 males, mean age: 74.4±7.6 years); 67% of patients had a history of smoking, 48% of hypertension, 37% of dyslipidemia and 22.8% of diabetes. The visual score was 21.28±7.99% at T0 and 26.54±9.34% at T1, respectively (T1-T0 5.26±6.13%, P<0.001). CAC score at T0 and at T1 was 537.93±839.94 and 759.98±1027.6, respectively (T1-T0 224.66±406.87, P<0.001). Mean follow-up time was 2.47±1.1 years. On multivariate analysis, male sex (HR=3.58, 95% CI: 1.14-11.2) and CAC score at T0 (HR=1.04, 95% CI: 1.01-1.07) correlated with mortality and cardiovascular events. CAC score at T0≥405 showed 82% sensitivity and 100% specificity for predicting mortality and adverse cardiovascular events.</p><p><strong>Conclusions: </strong>IPF patients with a CAC score at diagnosis ≥405 have a poor prognosis over a mid-term follow-up. A higher CAC score is associated with mortality and cardiovascular events.</p>","PeriodicalId":18671,"journal":{"name":"Minerva medica","volume":" ","pages":"815-824"},"PeriodicalIF":4.7,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45285402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Minerva medicaPub Date : 2023-12-01Epub Date: 2023-06-29DOI: 10.23736/S0026-4806.23.08753-0
Stefano Iuliano, Maria C Zagari, Gabriele Frasca Polara, Giovanna Rotella, Sandro LA Vignera, Emanuela A Greco, Marco T Liuzza, Antonio Aversa
{"title":"Global olfactory function correlates with global sexual functioning in men and women.","authors":"Stefano Iuliano, Maria C Zagari, Gabriele Frasca Polara, Giovanna Rotella, Sandro LA Vignera, Emanuela A Greco, Marco T Liuzza, Antonio Aversa","doi":"10.23736/S0026-4806.23.08753-0","DOIUrl":"10.23736/S0026-4806.23.08753-0","url":null,"abstract":"<p><strong>Background: </strong>Olfaction is intimately involved in reproductive behaviors. However, there is limited evidence about the relationship between olfactory and sexual functioning, and whether this relationship is modulated by gender. This study aimed to investigate the correlates between olfactory and sexual functioning in a cohort of young healthy individuals; secondary outcomes were the possible correlates between disgust and perceived vulnerability to illness, with particular relation to sexual attitudes.</p><p><strong>Methods: </strong>Between January 2019 and December 2022, we enrolled 125 participants (51 males and 74 females) without known sexual disorders. The mean age was 28.47±8.6, and the mean Body Mass Index (BMI) was 23.86±3.3 without major disease or concomitant drug assumption, except for nutraceutical use. Olfactory sensitivity was tested with the Sniffin' Sticks Test (SST). Body Odor Disgust Scale (BODS) and Perceived Vulnerability to Disease (PVD) questionnaires were administered for the evaluation of perceived susceptibility to illness along with the Sexual Attitude Scale (SAS) for the evaluation of sexual attitudes. Sexual function was evaluated by the Female Sexual Function Index (FSFI) and International Index of Erectile Function (IIEF) questionnaires, respectively.</p><p><strong>Results: </strong>Overall, a close relationship between sexual function and olfaction in both sexes (P<0.05) was found. In the male sample, better olfactive scores were positively correlated to all IIEF sub-domains but negatively with BMI and age, respectively (P<0.05). Moreover, olfaction was negatively correlated with a restrictive attitude towards sexuality (SAS) (P<0.05). The latter was also positively correlated with PVD (P<0.01). In the female sample, all FSFI subscales but sexual desire was positively correlated with olfaction (P<0.05).</p><p><strong>Conclusions: </strong>We herein confirm that olfactory capacities positively correlate with sexual behavior in both sexes. In males, these findings were mostly dependent upon increasing age and BMI. In females all domains of sexual function but sexual desire correlated with olfactory capacity, thus suggesting independent neural pathway activation for sexual desire. Finally, better olfactory capacities seem to determine sexual attitudes and disease avoidance behaviors irrespective of gender.</p>","PeriodicalId":18671,"journal":{"name":"Minerva medica","volume":" ","pages":"785-794"},"PeriodicalIF":4.7,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9749726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Minerva medicaPub Date : 2023-12-01Epub Date: 2022-03-22DOI: 10.23736/S0026-4806.22.07989-7
Teresa Díaz DE Terán, Paula González, Mónica González, Andrea Cerveró, Antonello Nicolini, Paolo Banfi, Paolo Solidoro, José J Napal, Carmen Valero
{"title":"Risk factors in developing retinal vein occlusion in subject with obstructive sleep apnea.","authors":"Teresa Díaz DE Terán, Paula González, Mónica González, Andrea Cerveró, Antonello Nicolini, Paolo Banfi, Paolo Solidoro, José J Napal, Carmen Valero","doi":"10.23736/S0026-4806.22.07989-7","DOIUrl":"10.23736/S0026-4806.22.07989-7","url":null,"abstract":"<p><strong>Background: </strong>Patients with obstructive sleep apnea (OSA) have a higher risk of developing vascular diseases. In this study, we evaluated the clinical profile of patients with OSA who develop retinal vein occlusion (RVO) compared with a population of OSA patients without RVO.</p><p><strong>Methods: </strong>We analyzed patients with OSA diagnosed with RVO (21 cases; mean of age 61 years. range 44-87 years. 67% men), belonging to a large cohort of people with long-term follow-up for RVO (up to 12 years). We compared them with 21 patients with OSA, without RVO, matched by age and gender, selected from the Sleep Unit Registry (control group).</p><p><strong>Results: </strong>There were no differences in the prevalence of arterial hypertension (AHT) or Diabetes mellitus (DM), but the RVO patients presented a higher diastolic blood pressure compared to controls (87.6±12.6 mmHg vs. 77.9±10.1 mmHg respectively). The polygraphic parameters were similar in both groups. The Apnea-Hypopnea Index (IHA) similar in both groups (30.4±20.9 RVO vs. 33.7±22.1 controls). In addition, RVO patients had a less favorable lipid profile, with higher total cholesterol (218±52 mg/dL vs. 179±41 mg/dL), higher LDL cholesterol (139±47 mg/dL vs. 107±32 mg/dL) and higher atherogenic indices: LDL/HDL (2.78±0.95 RVO vs. 2.03±0.67 controls) and total cholesterol/HDL (4.37±1.08 vs. 3.45±0.84). Among the cases, 81% had peripheral RVO (superior temporal branch in 20 out of 21 cases) and 19% had central RVO. A percentage of 62% of the cases received intravitreal antiangiogenic therapy and dexamethasone implants and 33% received argon laser photocoagulation.</p><p><strong>Conclusions: </strong>Poor control of cardiovascular risk factors, particularly dyslipidemias, in patients with OSA may lead to the development of this ocular complication.</p>","PeriodicalId":18671,"journal":{"name":"Minerva medica","volume":" ","pages":"825-831"},"PeriodicalIF":4.7,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40313236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Minerva medicaPub Date : 2023-12-01Epub Date: 2023-08-03DOI: 10.23736/S0026-4806.23.08501-4
Mohammad H Hodroj, Nathalie Akiki, Rayan Bou-Fakhredin, Ali T Taher
{"title":"Beta-thalassemia: is cure still a dream?","authors":"Mohammad H Hodroj, Nathalie Akiki, Rayan Bou-Fakhredin, Ali T Taher","doi":"10.23736/S0026-4806.23.08501-4","DOIUrl":"10.23736/S0026-4806.23.08501-4","url":null,"abstract":"<p><p>β-thalassemia is a monogenic disorder characterized by decreased hemoglobin production, resulting in chronic anemia. There are several factors affecting the clinical presentation of patients with β-thalassemia, and several complications such as iron overload or ineffective erythropoiesis have been linked to this disease. Until nowadays, several conservative therapies namely blood transfusions, iron chelation, and the FDA-approved drug Luspatercept have been adopted alongside other debatable permanent cures. Other clinical trials are being conducted to develop better and safer management techniques for these patients. This review will discuss the different treatment strategies of β-thalassemia including novel therapies, besides all possible curative therapies that are being developed for this disease.</p>","PeriodicalId":18671,"journal":{"name":"Minerva medica","volume":" ","pages":"850-860"},"PeriodicalIF":4.7,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9981792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}